Neonatal Med Search


Neonatal Med > Volume 24(3); 2017 > Article
Neonatal Medicine 2017;24(3):101-109.
DOI:    Published online August 31, 2017.
Clinical Trials for Preterm Infants' Neurodevelopment to the Norm: Erythropoietin and Nutritional Interventions.
Sook Hyun Park
Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.
Although the incidence of severe intraventicular hemorrhage and cystic periventricular leukomalacia in preterm infants has significantly decreased, approximately 10–15% of preterm survivors demonstrate cerebral palsy and 50–80% of extremely preterm infants demonstrate mild-to-severe neurodevelopmental impairment. Compared to term infants, preterm infants show a higher incidence of brain damage secondary to hypoxic injury, inflammation, and malnutrition. Clinical trials have evaluated outcomes following early administration of high dose erythropoietin and nutritional interventions including early aggressive nutrition, human breast milk, and long-chain polyunsaturated fatty acids supplementation to prevent preterm infants' neurodevelopmental impairment and improve neurodevelopmental outcome. Further studies are warranted to investigate the safety, optimal dose, timing, duration with respect to erythropoietin and nutritional interventions, and the optimization of a target population of preterm infants suited for interventions.
Key Words: Erythropoietin, Nutrition, Long-chain polyunsaturated fatty acids, Preterm infants
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 1 Crossref
  • 2,928 View
  • 49 Download


Browse all articles >

Editorial Office
34, Sajik-ro 8–gil(King’s Gargen 3 Block 1207), Jongno-gu, Seoul 03174, Republic of Korea
Tel: +82-2-730-1993    Fax: +82-2-730-1994    E-mail:                

Copyright © 2022 by The Korean Society of Neonatology.

Developed in M2PI

Close layer
prev next